Literature DB >> 8572924

Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on tryptophan and glucose homeostasis in the most TCDD-susceptible and the most TCDD-resistant species, guinea pigs and hamsters.

M Unkila1, M Ruotsalainen, R Pohjanvirta, M Viluksela, E MacDonald, J T Tuomisto, K Rozman, J Tuomisto.   

Abstract

We have previously reported that in rats 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) lethality is associated (although not necessarily causally) with changes in brain serotonin (5-HT) metabolism. In the present study, we have examined whether this holds for other species by comparing the effect of TCDD in the most TCDD-susceptible and the most TCDD-resistant species, guinea pigs and hamsters, respectively. Body weight gain of guinea pigs exposed to TCDD (0.3-2.7 micrograms/kg) diminished dose dependently, while the effect was marginal in hamsters (900-4600 micrograms/kg). Brain 5-hydroxyindoleacetic acid (the main metabolite of brain 5-HT), brain tryptophan (the precursor amino acid of 5-HT), and plasma free and total tryptophan were not affected at any dose in guinea pigs. In contrast, 4 days after exposure, the levels of plasma free and total tryptophan were consistently increased in hamsters. These, as well as brain tryptophan, were still elevated 10 days after exposure. TCDD did not affect plasma glucose level in either species. Liver glycogen was decreased in a dose-dependent manner in TCDD-treated guinea pigs as well as in their pair-fed controls on day 10. There was no change in liver glycogen in hamsters. The activity of the gluconeogenic enzyme, phosphoenolpyruvate carboxykinase was only depressed in hamsters by all doses of TCDD. We conclude that changes in tryptophan metabolism or in carbohydrate homeostasis cannot explain the wide interspecies differences in susceptibility to the acute lethality of TCDD, although they may correlate with some aspects of its toxicity in certain species.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8572924     DOI: 10.1007/s002040050231

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  18 in total

1.  Influence of L-tryptophan and its metabolites on gluconeogenesis in the isolated, perfused liver.

Authors:  C M Veneziale; P Walter; N Kneer; H A Lardy
Journal:  Biochemistry       Date:  1967-07       Impact factor: 3.162

2.  Key enzymes of gluconeogenesis are dose-dependently reduced in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats.

Authors:  L W Weber; M Lebofsky; H Greim; K Rozman
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

Review 3.  Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models.

Authors:  R Pohjanvirta; J Tuomisto
Journal:  Pharmacol Rev       Date:  1994-12       Impact factor: 25.468

4.  A paradoxical in vivo effect of L-tryptophan on the phosphoenolpyruvate carboxykinase of rat liver.

Authors:  D O Foster; P D Ray; H A Lardy
Journal:  Biochemistry       Date:  1966-02       Impact factor: 3.162

5.  Hypophagia-induced weight loss in mice, rats, and guinea pigs treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  C K Kelling; B J Christian; S L Inhorn; R E Peterson
Journal:  Fundam Appl Toxicol       Date:  1985-08

6.  Reduced activities of key enzymes of gluconeogenesis as possible cause of acute toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in rats.

Authors:  L W Weber; M Lebofsky; B U Stahl; J R Gorski; G Muzi; K Rozman
Journal:  Toxicology       Date:  1991-02       Impact factor: 4.221

7.  Dose response and time course of alterations in tryptophan metabolism by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the most TCDD-susceptible and the most TCDD-resistant rat strain: relationship with TCDD lethality.

Authors:  M Unkila; R Pohjanvirta; E MacDonald; J T Tuomisto; J Tuomisto
Journal:  Toxicol Appl Pharmacol       Date:  1994-10       Impact factor: 4.219

8.  Alterations in plasma tryptophan binding to albumin in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated Long-Evans rats.

Authors:  M Unkila; R Pohjanvirta; J T Tuomisto; J Tuomisto
Journal:  Eur J Pharmacol       Date:  1995-07-01       Impact factor: 4.432

9.  A bioluminescent assay for the determination of phosphoenolpyruvate carboxykinase activity in nanogram-sized tissue samples.

Authors:  M Wimmer
Journal:  Anal Biochem       Date:  1988-05-01       Impact factor: 3.365

10.  Toxicology of chlorinated dibenzo-p-dioxins.

Authors:  B A Schwetz; J M Norris; G L Sparschu; U K Rowe; P J Gehring; J L Emerson; C G Gerbig
Journal:  Environ Health Perspect       Date:  1973-09       Impact factor: 9.031

View more
  6 in total

1.  Exposure to Heptachlorodibenzo-p-dioxin (HpCDD) Regulates microRNA Expression in Human Lung Fibroblasts.

Authors:  Collynn F Woeller; Thomas H Thatcher; Juilee Thakar; Adam Cornwell; Matthew R Smith; Dean P Jones; Philip K Hopke; Patricia J Sime; Pamela Krahl; Timothy M Mallon; Richard P Phipps; Mark J Utell
Journal:  J Occup Environ Med       Date:  2019-12       Impact factor: 2.162

Review 2.  Aryl hydrocarbon receptor (AhR)-mediated signaling as a critical regulator of skeletal cell biology.

Authors:  Dima W Alhamad; Husam Bensreti; Jennifer Dorn; William D Hill; Mark W Hamrick; Meghan E McGee-Lawrence
Journal:  J Mol Endocrinol       Date:  2022-08-22       Impact factor: 4.869

3.  Association between the levels of biogenic amines and superoxide anion production in brain regions of rats after subchronic exposure to TCDD.

Authors:  James P Byers; Karilane Masters; Jeffrey G Sarver; Ezdihar A Hassoun
Journal:  Toxicology       Date:  2006-09-29       Impact factor: 4.221

Review 4.  Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review.

Authors:  Kyla W Taylor; Raymond F Novak; Henry A Anderson; Linda S Birnbaum; Chad Blystone; Michael Devito; David Jacobs; Josef Köhrle; Duk-Hee Lee; Lars Rylander; Anna Rignell-Hydbom; Rogelio Tornero-Velez; Mary E Turyk; Abee L Boyles; Kristina A Thayer; Lars Lind
Journal:  Environ Health Perspect       Date:  2013-05-07       Impact factor: 9.031

5.  Interspecies extrapolation by physiologically based pharmacokinetic modeling.

Authors:  Ahmed Ghallab
Journal:  EXCLI J       Date:  2015-12-21       Impact factor: 4.068

Review 6.  Species-Specific Differences in Aryl Hydrocarbon Receptor Responses: How and Why?

Authors:  Xiaoting Xu; Xi Zhang; Yuzhu Yuan; Yongrui Zhao; Hamza M Fares; Mengjiao Yang; Qing Wen; Reham Taha; Lixin Sun
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.